Study S001845

Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®. A Multi-centre, Open-label, Non-interventional Post-marketing Study to Investigate the Long-term Safety and Effectiveness of Ozempic® (Semaglutide) in Japanese Patients With Type 2 Diabetes Mellitus Under Normal Clinical Practice Condition

ClinicalTrials.gov record

Registration

Registration: NCT04469855
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 3217
Start: 2020-07-27
Primary completion: 2025-05-12
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:semaglutide
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1187-9072

Registered primary outcomes

Number of adverse events (AEs) [From baseline (day 0) to end of study (month 36)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.